Jatrorrhizine chlorideCAS# 6681-15-8 |
- Jatrorrhizine Hydrochloride
Catalog No.:BCC8193
CAS No.:960383-96-4
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 6681-15-8 | SDF | Download SDF |
| PubChem ID | 371256 | Appearance | Orange-red powder |
| Formula | C20H20ClNO4 | M.Wt | 373.83 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Synonyms | Neprotine chloride; Yatrorhizine chloride | ||
| Solubility | Soluble in chloroform and methan | ||
| Chemical Name | 2,9,10-trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-3-ol;chloride | ||
| SMILES | COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)O)OC)OC.[Cl-] | ||
| Standard InChIKey | JKMUUZMCSNHBAX-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C20H19NO4.ClH/c1-23-18-5-4-12-8-16-14-10-19(24-2)17(22)9-13(14)6-7-21(16)11-15(12)20(18)25-3;/h4-5,8-11H,6-7H2,1-3H3;1H | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Jatrorrhizine hydrochloride has lipid lowering effects, it can ameliorate hyperlipidemia via the suppression of lipogenesis and the enhancement of lipid oxidation in the liver. It exhibits a potent inhibitory effect toward neuraminidase of the H7N9 (N9) avian influenza virus, it also can potentiate the neuraminidase inhibitory effect of oseltamivir towards H7N9 influenza. Jatrorrhizine hydrochloride is a potential new antimelanoma drug candidate, can inhibit the proliferation and neovascularization of C8161 metastatic melanoma cells with low toxicity. |
| Targets | PPAR | Influenza virus |
| In vitro | Jatrorrhizine hydrochloride inhibits the proliferation and neovascularization of C8161 metastatic melanoma cells.[Pubmed: 23695011]Anticancer Drugs. 2013 Aug;24(7):667-76.Malignant melanoma is the most aggressive form of skin cancer. Although various antimelanoma approaches have been used in the clinics to treat the disease over the last three decades, none of the drugs significantly prolonged the survival of metastatic melanoma patients; hence, effective drugs against metastatic melanoma are highly desired.
|
| In vivo | Jatrorrhizine hydrochloride attenuates hyperlipidemia in a high-fat diet-induced obesity mouse model.[Pubmed: 27573054 ]Mol Med Rep. 2016 Oct;14(4):3277-84.Jatrorrhizine Hydrochloride (JH) is an active component of the traditional Chinese herb Coptis chinensis, which has been used to prevent and treat metabolic disorders. Hyperlipidemia is one of the principal factors underlying numerous metabolic diseases, including diabetes and obesity. Therefore, the aim of the present study was to investigate the lipid lowering effects of JH treatment in vivo in an obesity mouse model. JH-treated hyperlipidemic mice exhibited a reduction in body weight, as well as improved glucose tolerance and insulin sensitivity. In addition, JH‑treated hyperlipidemic mice exhibited reduced serum triglyceride, total cholesterol and low‑density lipoprotein cholesterol levels, as well as increased high‑density lipoprotein cholesterol levels compared with untreated mice fed a high‑fat diet. Notably, JH treatment ameliorated the pathophysiological changes observed in the livers of hyperlipidemic mice. At the molecular level, JH downregulated the hepatic mRNA expression levels of SREBP‑1c and FAS, and induced PPAR‑α and CPT1A mRNA expression in hyperlipidemic mice. These findings suggest that JH ameliorates hyperlipidemia via the suppression of lipogenesis and the enhancement of lipid oxidation in the liver. |
| Kinase Assay | Jatrorrhizine Hydrochloride potentiates the neuraminidase inhibitory effect of oseltamivir towards H7N9 influenza[Reference: WebLink]Rsc Adv., 2015, 5(80):64937-43.A Chinese natural product, Jatrorrhizine Hydrochloride (JH), exhibited potent inhibitory effect toward neuraminidase of the H7N9 (N9) avian influenza virus.
|
Jatrorrhizine chloride Dilution Calculator
Jatrorrhizine chloride Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.675 mL | 13.3751 mL | 26.7501 mL | 53.5003 mL | 66.8753 mL |
| 5 mM | 0.535 mL | 2.675 mL | 5.35 mL | 10.7001 mL | 13.3751 mL |
| 10 mM | 0.2675 mL | 1.3375 mL | 2.675 mL | 5.35 mL | 6.6875 mL |
| 50 mM | 0.0535 mL | 0.2675 mL | 0.535 mL | 1.07 mL | 1.3375 mL |
| 100 mM | 0.0268 mL | 0.1338 mL | 0.2675 mL | 0.535 mL | 0.6688 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Hernandezine
Catalog No.:BCN7793
CAS No.:6681-13-6
- (+/-)-Forbesione
Catalog No.:BCN6423
CAS No.:667914-50-3
- Syringaresinol-di-O-glucoside
Catalog No.:BCN2600
CAS No.:66791-77-3
- Impurity B of Calcitriol
Catalog No.:BCC1645
CAS No.:66791-71-7
- Platycodin A
Catalog No.:BCN7997
CAS No.:66779-34-8
- Esculin Sesquihydrate
Catalog No.:BCC8324
CAS No.:66778-17-4
- 6,8-Diprenylorobol
Catalog No.:BCN4602
CAS No.:66777-70-6
- Diosbulbin D
Catalog No.:BCN4218
CAS No.:66756-57-8
- NSC 109555 ditosylate
Catalog No.:BCC7540
CAS No.:66748-43-4
- MeBIO
Catalog No.:BCC3898
CAS No.:667463-95-8
- BIO-acetoxime
Catalog No.:BCC6076
CAS No.:667463-85-6
- GSK-3 Inhibitor IX (BIO)
Catalog No.:BCC4510
CAS No.:667463-62-9
- Magnoflorine chloride
Catalog No.:BCN2405
CAS No.:6681-18-1
- Linagliptin (BI-1356)
Catalog No.:BCC2110
CAS No.:668270-12-0
- LDN 57444
Catalog No.:BCC2087
CAS No.:668467-91-2
- Halobetasol Propionate
Catalog No.:BCC4664
CAS No.:66852-54-8
- H-D-Leu-OBzl.HCl
Catalog No.:BCC2682
CAS No.:66866-69-1
- Talniflumate
Catalog No.:BCC7391
CAS No.:66898-62-2
- 1,2-O-Isopropylidene-beta-D-fructopyranose
Catalog No.:BCN1383
CAS No.:66900-93-4
- α-Conotoxin PIA
Catalog No.:BCC5976
CAS No.:669050-68-4
- Beta-Belladonnine
Catalog No.:BCN1893
CAS No.:6696-63-5
- Tianeptine
Catalog No.:BCC1999
CAS No.:66981-73-5
- Thiamine hydrochloride
Catalog No.:BCN2225
CAS No.:67-03-8
- EGTA
Catalog No.:BCC7491
CAS No.:67-42-5
Jatrorrhizine hydrochloride inhibits the proliferation and neovascularization of C8161 metastatic melanoma cells.[Pubmed:23695011]
Anticancer Drugs. 2013 Aug;24(7):667-76.
Malignant melanoma is the most aggressive form of skin cancer. Although various antimelanoma approaches have been used in the clinics to treat the disease over the last three decades, none of the drugs significantly prolonged the survival of metastatic melanoma patients; hence, effective drugs against metastatic melanoma are highly desired. In this study, we explored an antimetastatic melanoma agent derived from traditional Chinese medicinal herbs and found that jatrorrhizine hydrochloride (JH), an active component of the traditional Chinese medicinal herb Coptis chinensis, inhibited the proliferation and neovascularization of C8161 human metastatic melanoma cells. JH suppressed C8161 cell proliferation in a dose-dependent manner, with a half-maximal inhibitory concentration of 47.4+/-1.6 mumol/l; however, it did not induce significant cellular apoptosis at doses up to 320 mumol/l. Mechanistic studies showed that JH-induced C8161 cell cycle arrest at the G0/G1 transition, which was accompanied by overexpression of the cell cycle-suppressive genes p21 and p27 at higher doses. Moreover, JH reduced C8161 cell-mediated neovascularization in vitro and in vivo and impeded the expression of the gene for VE-cadherin, a key protein in tumor vasculogenic mimicry and angiogenesis. Taken together, the effective inhibitory effects of JH on metastatic melanoma cell proliferation and neovascularization with low toxicity suggest that JH is a potential new antimelanoma drug candidate.
Jatrorrhizine hydrochloride attenuates hyperlipidemia in a high-fat diet-induced obesity mouse model.[Pubmed:27573054]
Mol Med Rep. 2016 Oct;14(4):3277-84.
Jatrorrhizine hydrochloride (JH) is an active component of the traditional Chinese herb Coptis chinensis, which has been used to prevent and treat metabolic disorders. Hyperlipidemia is one of the principal factors underlying numerous metabolic diseases, including diabetes and obesity. Therefore, the aim of the present study was to investigate the lipid lowering effects of JH treatment in vivo in an obesity mouse model. JH-treated hyperlipidemic mice exhibited a reduction in body weight, as well as improved glucose tolerance and insulin sensitivity. In addition, JHtreated hyperlipidemic mice exhibited reduced serum triglyceride, total cholesterol and lowdensity lipoprotein cholesterol levels, as well as increased highdensity lipoprotein cholesterol levels compared with untreated mice fed a highfat diet. Notably, JH treatment ameliorated the pathophysiological changes observed in the livers of hyperlipidemic mice. At the molecular level, JH downregulated the hepatic mRNA expression levels of SREBP1c and FAS, and induced PPARalpha and CPT1A mRNA expression in hyperlipidemic mice. These findings suggest that JH ameliorates hyperlipidemia via the suppression of lipogenesis and the enhancement of lipid oxidation in the liver.
